发明名称 Lipopolysaccharide-Targeted Peptide Mimic Vaccine Against Q Fever
摘要 A vaccine and method of vaccination for conferring immunity to Q fever is described. The vaccine comprises a polypeptide with a sequence of SLTWHKHELHRK (m1E41920) or SPPWHKHELHRK (m1E44), or at least 90% identity to m1E41920 or m1E44. Constructs are also provided for use in vaccination and treatment of Q fever. A method to identify and generate new vaccines to prevent diseases caused by intracellular Gram-negative bacteria is also described.
申请公布号 US2016304587(A1) 申请公布日期 2016.10.20
申请号 US201615195586 申请日期 2016.06.28
申请人 ZHANG GUOQUAN 发明人 ZHANG GUOQUAN
分类号 C07K16/12;C12N15/10 主分类号 C07K16/12
代理机构 代理人
主权项 1. An isolated humanized antibody or antigen-binding fragment thereof for protection against gram negative intracellular bacterial infection, that specifically binds to a lipopolysaccharide-based epitope in gram negative bacteria, wherein the humanized antibody or antigen-binding fragment thereof competes for binding to a lipopolysaccharide-based peptide mimetic sequence of SLTWHKHELHRK (SEQ ID NO: 7) or SPPWHKHELHRK (SEQ ID NO: 8), or a peptide sequence having at least 90% identity to SLTWHKHELHRK (SEQ ID NO: 7) or SPPWHKHELHRK (SEQ ID NO: 8), or pharmaceutically acceptable salt thereof.
地址 COLUMBIA MO US
您可能感兴趣的专利